Albellar, Joey I.
HRN: 06-77-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2023
CEFAZOLIN 1GM (VIAL)
06/17/2023
06/24/2023
IV
500mg
Q6hrs
For Left L1-L2 UBE Foraminoplasty
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes